Benzinga | May 13, 2021 04:19PM EDT

Bolt Biotherapeutics Q1 EPS $(1.14) Up From $(4.16) YoY

Bolt Biotherapeutics (NASDAQ:BOLT) reported quarterly losses of $(1.14) per share. This is a 72.6 percent increase over losses of $(4.16) per share from the same period last year.